| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6075690 | Journal of Investigative Dermatology | 2015 | 7 Pages |
Abstract
Melanoma is a therapy-resistant skin cancer due to numerous mechanisms supporting cell survival. Although components of melanoma cytoprotective mechanisms are overexpressed in many types of tumors, some of their regulators are characteristic for melanoma. Several genes mediating pro-survival functions have been identified as direct targets of microphthalmia-associated transcription factor (MITF), a melanocyte-specific modulator also recognized as a lineage addiction oncogene in melanoma. BRAFV600E and other proteins deregulated in melanoma influence MITF expression and activity, or they are the partners of MITF in melanoma response to radiotherapy and chemotherapeutics. In this review, the pro-survival activity of MITF is discussed.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mariusz L. Hartman, Malgorzata Czyz,